LEO 32731 - A Study in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions

Healthy Subjects

Interventions

DRUG

LEO 32731

"* Part 1 and 2: Oral single dose of oral solution or capsule~* Part 3: Twice daily dose of oral solution or capsule for 7 days"

Trial Locations (1)

Covance Clinical Research Unit Ltd., Leeds